Dr. Reddy’s Laboratories a566h

Business

Dr. Reddy’s Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market 4f79

Praveen Comments Off on Dr. Reddy’s Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent […]

Business

Dr. Reddy’s Laboratories announces the launch of Bortezomib for Injection 3.5 mg/vial 35yr

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Bortezomib for Injection 3.5 mg/vial

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Bortezomib for Injection 3.5 mg/vial, approved by the U.S. Food […]

Business

Dr. Reddy’s Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market 1j4r18

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. May 15, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Daptomycin […]